NDC codes

413472 NDC codes with hospital pricing data in the network.

• NDC 00904-6732-04 — Colchicine 0.6 mg capsuleAI (110 hospitals, 132 samples)
• NDC 16729-0415-01 — Doxazosin 8 mg tabletsAI (97 hospitals, 132 samples)
• NDC 62332-0426-31 — Benzonatate 100 mg capsulesAI (45 hospitals, 132 samples)
• NDC 99999-0000-42 — Phenytoin oral liquid (125 mg per 5 mL)AI (22 hospitals, 51–132 samples)
• NDC 00904-7082-04 — Nifedipine extended-release 90 mg tabletAI (98 hospitals, 132 samples)
• NDC 50268-0109-15 — Benazepril 5 mg tabletAI (153 hospitals, 132 samples)
• NDC 65862-0229-60 — Lamotrigine 150 mg tabletsAI (84 hospitals, 132 samples)
• NDC 43547-0296-03 — Febuxostat 80 mg tabletAI (26 hospitals, 132 samples)
• NDC 60687-0653-01 — Potassium chloride extended-release 10 mEq capsuleAI (43 hospitals, 132 samples)
• NDC 00703-9032-01 — Amikacin 500 mg/2 mL injectionAI (131 hospitals, 114–132 samples)
• NDC 16571-0126-06 — tolterodine 1 mg tabletAI (124 hospitals, 132 samples)
• NDC 64980-0156-03 — Probiotic capsules (Lactobacillus and Bifidobacterium blend)AI (16 hospitals, 132 samples)
• NDC 00121-1465-30 — Potassium chloride oral liquid 10%AI (25 hospitals, 132 samples)
• NDC 09999-9002-04 — Gentamicin 40 mg/mL injectionAI (10 hospitals, 59–131 samples)
• NDC 00054-3177-05 — DEXAMETHASONE, ORAL, 0.25 MG (2 hospitals, 23–131 samples)
• NDC 00009-0912-05 — Hydrocortisone sodium succinate injection 500 mgAI (24 hospitals, 23–131 samples)
• NDC 00186-0863-61 — Ropivacaine local anesthetic injection 0.5%, 30 mLAI (32 hospitals, 23–131 samples)
• NDC 00409-7992-09 — Dextrose 5% and quarter-normal saline IV solution with potassiumAI (17 hospitals, 77–131 samples)
• NDC 50090-7037-00 — EPINEPHRINE PER 0.1 MG (7 hospitals, 41–131 samples)
• NDC 23559-0000-00 — LEVETIRAC 500MG/NS 50MLPB (1 hospital, 41–131 samples)
• NDC 25021-0652-31 — Ropivacaine 150 mg/30 mL injectionAI (41 hospitals, 23–131 samples)
• NDC 50881-0034-12 — Axatilimab-csfr intravenous solution, 50 mg/mLAI (166 hospitals, 32–131 samples)
• NDC 63824-0008-32 — Guaifenesin 600 mg extended-release tablets, 20-count blister packAI (199 hospitals, 32–131 samples)
• NDC 00310-1349-30 — Osimertinib 40 mg tabletsAI (63 hospitals, 77–131 samples)
• NDC 17478-0931-01 — Calcitriol 1 mcg/mL injection, 1 mL ampuleAI (379 hospitals, 112–130 samples)
• NDC 50268-0527-11 — Methotrexate 2.5 mg tabletsAI (189 hospitals, 121–130 samples)
• NDC 58394-0633-03 — Recombinant coagulation factor IX 250 unit IV solutionAI (215 hospitals, 112–130 samples)
• NDC 62756-0060-40 — Epoprostenol injection vialAI (645 hospitals, 112–130 samples)
• NDC 68094-0101-20 — Phentolamine 5 mg injectionAI (575 hospitals, 112–130 samples)
• NDC 68180-0377-03 — Losartan potassium 50 mg tabletsAI (96 hospitals, 13–130 samples)
• NDC 70594-0023-04 — Colistimethate sodium injection, 150 mg vialAI (170 hospitals, 112–130 samples)
• NDC 70655-0002-06 — Fluconazole 200 mg in saline IV premixAI (167 hospitals, 13–130 samples)
• NDC 72611-0860-04 — Acetylcysteine 20% intravenous solutionAI (189 hospitals, 13–130 samples)
• NDC 338040903 — Lidocaine IV infusion in dextrose solutionAI (104 hospitals, 13–130 samples)
• NDC 641141035 — Digoxin injection, 0.25 mg per mLAI (222 hospitals, 13–130 samples)
• NDC 00338-0411-02 — Lidocaine IV infusion in dextrose solutionAI (486 hospitals, 112–130 samples)
• NDC 00078-0467-91 — Deferoxamine 500 mg injectionAI (267 hospitals, 112–130 samples)
• NDC 00093-9018-19 — Cyclosporine 25 mg oral capsulesAI (362 hospitals, 112–130 samples)
• NDC 00143-9564-01 — Phentolamine mesylate injection 5 mgAI (811 hospitals, 112–130 samples)
• NDC 00264-3183-11 — Meropenem 500 mg IV piggyback in salineAI (199 hospitals, 13–130 samples)
• NDC 00527-5160-82 — Mycophenolate mofetil oral suspension powderAI (243 hospitals, 112–130 samples)
• NDC 50268-0144-15 — Buprenorphine and naloxone sublingual tabletAI (235 hospitals, 13–130 samples)
• NDC 55150-0328-10 — Naloxone injection 0.4 mg/mL, 10 mL vialAI (139 hospitals, 13–130 samples)
• NDC 60505-0253-03 — Clopidogrel 75 mg tabletsAI (77 hospitals, 13–130 samples)
• NDC 63323-0099-03 — Sodium chloride intravenous solutionAI (123 hospitals, 31–130 samples)
• NDC 66302-0310-01 — Treprostinil diolamine 1 mg extended-release tabletsAI (152 hospitals, 58–130 samples)
• NDC 67457-0212-02 — argatroban 100 mg/mL intravenous solutionAI (416 hospitals, 112–130 samples)
• NDC 68382-0826-14 — Tamoxifen 10 mg tabletsAI (77 hospitals, 13–130 samples)
• NDC 68462-0760-10 — Epinephrine 1 mg/mL injectionAI (103 hospitals, 112–130 samples)
• NDC 69238-1595-02 — Mycophenolate mofetil oral suspension powderAI (215 hospitals, 112–130 samples)